Onco3R Therapeutics

Biotechnology Research • Leuven, Flemish Region, Belgium • 11-20 Employees

Company overview

Headquarters	Leuven, Flemish Region, Belgium
Website	onco3r.com
NAICS	541714
Keywords	Biotech, R&D, Drug Discovery, Oncology, Drug Development, Immunology
Founded	2025
Employees	11-20

Key Contacts at Onco3R Therapeutics

Evelien Micholt

Head Of It And Operations - Senior Director

Pierre Raboisson

Chief Executive Officer Onco3R Therapeutics

Lieselotte Lauwers

Finance And Procurement Director

Sandrine Grosse

Associate Director, Medicinal Chemistry

Stephane De Cesco

Director Of Computational Drug Design & Data Sciences

Lijs Beke

Head Of Oncology, Senior Director

Bart Stoops

Director Dmpk

Ellen Lanckacker

Associate Director

Sandrine Vendeville

Co-Founder & Vp, Head Of Medicinal Chemistry

Onco3R Therapeutics Email Formats

Onco3R Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@onco3r.com), used 95.2% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@onco3r.com	95.2%
{first initial}.{second initial}{last name}	j.odoe@onco3r.com	4.8%

About Onco3R Therapeutics

At Onco3R Therapeutics, we are driven by our purpose to transform the lives of patients with cancer and immune diseases through precision-designed, best-in-class therapies. With over 150 years of combined R&D experience, our team brings deep expertise in disease biology, drug discovery, and translational science. We focus on clinically validated targets and select the right therapeutic modality, small or large molecules, to match the underlying biology. Our mission is to develop safer, more effective medicines in oncology and immunology that truly make a difference for patients. By learning from past clinical challenges and applying cutting-edge technologies, we aim to de-risk early-stage development and accelerate the delivery of innovative treatments with real-world impact.

Onco3R Therapeutics revenue & valuation

Annual revenue	$1,539,990
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,000,000
Total funding	No funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

C-Suite

Head

Employees by Department

Onco3R Therapeutics has 9 employees across 5 departments.

Departments

Number of employees

Funding Data

Onco3R Therapeutics has never raised funding before.

Frequently asked questions

Onco3R Therapeutics is located in Leuven, Flemish Region, BE.

Onco3R Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Onco3R Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.